Medeva Europe Limited

Bridget Kathleen Mapleson

Philip J Sizer

A method of removing bacterial endotoxin from a pharmaceutical process solution is disclosed. In one embodiment, the method comprises treating the solution with a surfactant effective to dissociate the endotoxin from a pharmaceutical drug or vaccine substance in the solution, and then filtering the solution through a molecular cut-off filter having a pore size effective to retain the pharmaceutical drug or vaccine substance but allow the dissociated bacterial endotoxin to pass therethrough.

Growing community of inventors

Liverpool, United Kingdom

Bridget Kathleen Mapleson